Advisors Bring Extensive Experience in
Developing Medical Food to Complement Prescription
Antidepressants
BETHESDA, Md., April 16,
2024 /PRNewswire/ -- HedoniaUSA, a mental wellness
company, announced the formation of its Scientific Board of
Advisors. Currently developing a new medical food to address the
unique nutritional needs associated with depression, the Advisors
will help guide mental health research initiatives and foster
scientific rigor, integrity, and innovation.
HedoniaUSA Board brings extensive
experience in developing medical food to complement prescription
antidepressants
"More than 20 million people in the U.S. struggle with
depression – it's our mission to deliver breakthrough mental health
solutions to help them," said Dany
Sfeir, CEO of HedoniaUSA. "With their extensive experience
and expertise, the addition of the Advisors to our team will help
propel us to the forefront of medical innovation."
The HedoniaUSA Board includes:
- Alexander Vuckovic,
MD, Founder and Former CEO at HedoniaUSA. Vuckovic's
leadership, organizational direction, and reputation as one of the
most experienced clinical psychopharmacologists in the United States has shaped his passion for
revolutionizing antidepressant therapy. HedoniaUSA is Vuckovic's
brainchild and career capstone in his quest for finding alternative
approaches to depression management.
- Derek Tobin, PhD,
Product Development and Clinical Science Manager at Epax
Norway. A former clinical researcher at GE Healthcare and BASF,
Tobin has a proven track record for providing strategic,
regulatory, and clinical expertise for the development of nutrition
and pharmaceutical products. He brings eight years of experience in
omega-3 fish oil product development.
- Jerome Sarris,
PhD, Executive Director at Psychae Institute. With
nearly 30 years of experience, Sarris' mission is to advance
rigorous scientific research on psychoactive plant medicines and
nutraceutical compounds to enhance global mental health. He has
close to 250 academic and research papers, primarily in the mood
disorders field, and was named one of Australia's Top 250 researchers.
- Joseph Firth, PhD,
UKRI Research Fellow at The University of Manchester. Internationally ranked as one
of the most highly cited scientists in lifestyle medicine,
nutritional psychiatry, and mental health, Firth is the lead-author
of the Lancet Commission on Physical Health for Mental Illness and
is co-author of the European Psychiatric Association's 2024
Guidelines on Lifestyle Psychiatry.
"I'm dedicated to finding solutions to anxiety and mood
disorders through nutraceutical psychopharmacology," said Sarris.
"When I discovered Hedonia's science-backed mission to rebalance
the brain through a nutrient-based, real-food product, it felt
natural to get involved. I am proud to help bring Hedonia to those
who can benefit from it and see what else we can develop
together."
Additional information on HedoniaUSA and its Advisory Board
members can be found here.
About HedoniaUSA, Inc.:
HedoniaUSA is a leader in the nutritional management of
depression with a focus on easing the burden for people suffering
from this mental disorder by creating nature-based,
non-pharmaceutical products aimed at enhancing medication response.
The mental fitness and wellness company is currently both
developing and using revolutionary technologies to create new
delivery methods for ingestible and curated supplements that will
enhance customer wellness.
For more information, visit www.hedonia.com.
Contact:
HedoniaUSA Public Relations
pr@hedoniausa.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/hedoniausa-inc-appoints-scientific-board-of-advisors-302118141.html
SOURCE HedoniaUSA